Although multiple factors, such as upregulated expression of MGMT and multidrug resistance proteins, were reported to limit the toxicity of TMZ in glioma cells [3, 4], emerging evidence has revealed that autophagy plays a crucial role in protecting glioma cells against TMZ treatment [5, 6]. This evidence concerns the gene MGMT and central nervous system cancer.